Fairfax Station, VA, United States of America

Ziad Sahab

This inventor holds 1 USPTO granted patent. Top assignee: Georgetown University. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ziad Sahab. Retrieved from https://idiyas.com/inventor/ziad-sahab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ziad Sahab

Introduction: Ziad Sahab, an accomplished inventor based in Fairfax Station, Virginia, has made significant strides in the field of biomedical research. His focus on small molecule inhibitors has implications for treating cancer and neurological disorders, marking a pivotal development in therapeutic interventions.

Latest Patents: Ziad holds a patent for "Small Molecule Inhibitors of AGBL2." This innovative approach offers new methods for utilizing these inhibitors to address serious health conditions, including various forms of cancer and neurologic disorders.

Career Highlights: Ziad Sahab is affiliated with Georgetown University, where he has contributed to advancing medical research and innovation. His work at this esteemed institution has positioned him as a prominent figure in the academic and scientific communities.

Collaborations: Throughout his career, Ziad has collaborated with esteemed colleagues, including Stephen W. Byers and Sivanesan Dakshanamurthy. These collaborations enhance the potential for groundbreaking discoveries and foster a collaborative research environment.

Conclusion: Ziad Sahab's dedication to innovation in biomedical research exemplifies the crucial role inventors play in advancing our understanding of treatment methodologies. His patent on small molecule inhibitors not only showcases his inventive spirit but also holds promise for addressing complex health challenges in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…